![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 11, 2021 11:45:39 AM
Published on 30 Jan 2021 | 1 min read
Chris Bailey
Principal, Rouse Consultancy
+86 21 3251 9966
Fund raising to enable development and launch of breast cancer detection wearable device
Cyrcadia is an innovative wearable medical device that screens for breast cancer using AI to detect metabolic changes in breast tissue that correlate to malignant tumor formation.
Rouse supported the negotiation with the US parent company for formation of special-purpose vehicles for licensing the technology into the Asia-Pacific. It negotiated key agreements for the company with suppliers, clinical institutions and other commercial partners and managed its IP portfolio Rouse supported due diligence and negotiations around Cyrcadia’s Seed round funding, where the company secured $3.6M, lead by one of China’s AI champions, iFlytek. Rouse acts as legal and commercial advisor to the company on an ongoing basis.
Rob Royea, CEO and Chairman “Chris and his team were instrumental in structuring the licensing and JV deal to form Cyrcadia Asia, to support the company to establish several of its key strategic relationship and obtain funding”.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM